Published in J Natl Cancer Inst on June 01, 1974
Comparison between macrophage activation and enhancement of nonspecific resistance to tumors by mycobacterial immunoadjuvants. Proc Natl Acad Sci U S A (1975) 1.91
Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects. Clin Exp Immunol (1978) 1.46
Expression of a new cell surface antigen on activated murine macrophages. J Exp Med (1977) 1.21
Apoprotein E is synthesized and secreted by resident and thioglycollate-elicited macrophages but not by pyran copolymer- or bacillus Calmette-Guerin-activated macrophages. J Exp Med (1983) 1.16
Studies of macrophage function during Trichinella spiralis infection in mice. Immunology (1979) 1.15
The tumoricidal properties of inflammatory tissue macrophages and multinucleate giant cells. Am J Pathol (1979) 0.99
Inhibition of host resistance by nutritional hypercholesteremia. Infect Immun (1979) 0.93
Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity. Br J Cancer (1978) 0.92
Induction of cytotoxic peritoneal exudate cells by T-cell immune adjuvants of the beta(1 leads to 3) glucan-type lentinan and its analogues. Immunology (1980) 0.86
Antiviral effect of pyran against systemic infection of mice with herpes simplex virus type 2. Antimicrob Agents Chemother (1976) 0.78
Enhancement of resistance to murine osteogenic sarcoma in vivo by an extract of Brucella abortus (Bru-Pel): association with activation of reticuloendothelial system macrophages. Infect Immun (1979) 0.75
Synthesis and properties of antiprotein antibodies of sheep: secondary antibody response. Am J Vet Res (1972) 6.26
Neonatal salmonella meningitis complicated by cerebral abscesses. West J Med (1977) 5.55
Review of the biology of Quercetin and related bioflavonoids. Food Chem Toxicol (1995) 3.45
Career intentions of medical students trained in six sub-Saharan African countries. Educ Health (Abingdon) (2011) 2.54
Intramuscular injections in children. Pediatrics (1982) 2.43
Biodegradation of hexahydro-1,3,5-trinitro-1,3,5-triazine. Appl Environ Microbiol (1981) 2.31
Hemangioendothelial sarcoma of liver from chronic arsenic intoxication by Fowler's solution. Cancer (1968) 2.22
Identification of biotransformation products from 2,4-dinitrotoluene. Appl Environ Microbiol (1978) 2.07
Microbial transformation of 14C-labeled 2,4,6-trinitrotoluene in an activated-sludge system. Appl Environ Microbiol (1978) 2.04
Lack of association between bacteriuria and symptoms in the elderly. Am J Med (1986) 1.85
Macrophage nomenclature: where are we going? J Reticuloendothel Soc (1980) 1.81
Measuring the effects of an international health professions faculty development fellowship: the FAIMER Institute. Med Teach (2010) 1.68
Thermophilic biotransformations of 2,4,6-trinitrotoluene under simulated composting conditions. Appl Environ Microbiol (1982) 1.59
Macrophage regulation of mitogen-induced blastogenesis. I. Demonstration of inhibitory cells in the spleens and peritoneal exudates of mice. Cell Immunol (1977) 1.45
Primary amoebic meningoencephalitis with Naegleria fowleri: clinical review. Pediatr Neurol (1996) 1.44
Microbial degradation of glycerol nitrates. Appl Environ Microbiol (1978) 1.43
Comparison of antiviral and antitumor activity of activated macrophages. Cell Immunol (1977) 1.42
Age-related cellular resistance of the chicken embryo to viral infections. I. Interferon and natural resistance to myxoviruses and vesicular stomatitis virus. J Infect Dis (1970) 1.42
Fungal susceptibility of polyurethanes. Appl Microbiol (1968) 1.41
Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial. Cancer (1993) 1.40
T cell independence of bleomycin-induced pulmonary fibrosis. J Leukoc Biol (1999) 1.39
Kinetics of changes in peritoneal cell populations following acute inflammation. Cell Immunol (1989) 1.37
Macrophage extrinsic antiviral activity during herpes simplex virus infection. J Gen Virol (1980) 1.34
Innovative mentoring programs to promote gender equity in academic medicine. Acad Med (2001) 1.23
Have we found the "definitive cancer biomarker"? The diagnostic and therapeutic implications of human chorionic gonadotropin-beta expression as a key to malignancy. Cancer (1995) 1.22
Expression of a new cell surface antigen on activated murine macrophages. J Exp Med (1977) 1.21
Review of the macrophage disappearance reaction. J Leukoc Biol (1995) 1.20
Interferon induction in man by a synthetic polyanion of defined composition. N Engl J Med (1967) 1.19
Spectrum of ovine immunoglobulins. Proc Soc Exp Biol Med (1968) 1.19
Stimulation of antibody formation by pyran copolymer. Proc Soc Exp Biol Med (1970) 1.15
Viruses and the versatile macrophage. Br Med Bull (1985) 1.15
Immunomodulator-induced resistance against herpes simplex virus. Proc Soc Exp Biol Med (1977) 1.14
Changes in macrophage ectoenzymes associated with anti-tumor activity. J Immunol (1980) 1.13
The weakening of the Oslerian tradition. The changing emphasis in departments of medicine. JAMA (1978) 1.13
Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2. J Immunol (1977) 1.12
Antibacterial and immunostimulating casein-derived substances from milk: casecidin, isracidin peptides. Food Chem Toxicol (1996) 1.12
Macrophage functions in beige (Chédiak-Higashi syndrome) mice. Cancer Res (1980) 1.11
Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer (1994) 1.11
Protection against acute lethal viral infections with the native steroid dehydroepiandrosterone (DHEA). J Med Virol (1988) 1.10
The role of macrophages in wound repair: a review. Plast Reconstr Surg (1981) 1.10
Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine. Infect Immun (1977) 1.09
Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA). Mol Cell Biochem (1994) 1.08
Chemotherapy as an adjuvant to surgery for colorectal cancer. Ann Surg (1975) 1.07
Capacity building in medical education and health outcomes in developing countries: the missing link. Educ Health (Abingdon) (2007) 1.05
Macrophage regulation of mitogen-induced blastogenesis. II. Mechanism of inhibition. Cell Immunol (1977) 1.04
Bleomycin-induced pulmonary fibrosis is independent of eosinophils. J Leukoc Biol (2000) 1.03
Repression of interferon action: induced dedifferentiation of embryonic cells. Science (1971) 1.03
Advancing women and closing the leadership gap: the Executive Leadership in Academic Medicine (ELAM) program experience. J Womens Health Gend Based Med (2001) 1.02
Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1. Infect Immun (1981) 1.01
Differential effects of chronic monocyte depletion on macrophage populations. Lab Invest (1983) 1.01
Pineal control of aging: effect of melatonin and pineal grafting on aging mice. Proc Natl Acad Sci U S A (1994) 0.99
Aplasia cutis congenita complicated by sagittal sinus hemorrhage. Pediatrics (1980) 0.99
Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect Immun (1979) 0.99
Biphasic response of the reticuloendothelial system (RES) induced by pyran copolymer. J Reticuloendothel Soc (1970) 0.98
Comparative therapeutic efficacy of recombinant interferons-alpha, -beta, and -gamma against alphatogavirus, bunyavirus, flavivirus, and herpesvirus infections. J Interferon Res (1990) 0.98
High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. J Neurooncol (1998) 0.97
Mutagenicity of 2,4,6-trinitrotoluene-surfactant complexes. Bull Environ Contam Toxicol (1982) 0.97
Familial porencephaly. Arch Neurol (1983) 0.96
Effect of inapparent murine hepatitis virus infections on macrophages and host resistance. J Leukoc Biol (1986) 0.96
Effect of Tilorone hydrochloride and congeners on reticuloendothelial system, tumors, and the immune response. Cancer Res (1972) 0.96
Biodegradation of glycidol and glycidyl nitrate. Appl Environ Microbiol (1982) 0.96
A multisite collaborative for the development of interdisciplinary education in continuous improvement for health professions students. Acad Med (1996) 0.95
Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity. J Immunol (1978) 0.94
Friedreich's ataxia with acute cardiomyopathy. Am J Dis Child (1980) 0.93
Inhibition of host resistance by nutritional hypercholesteremia. Infect Immun (1979) 0.93
Antiviral activity and side effects of polyriboinosinic-cytidylic acid complexes as affected by molecular size. Proc Natl Acad Sci U S A (1972) 0.93
Stability of minute virus of mice to chemical and physical agents. Appl Microbiol (1974) 0.93
Selective depletion of liver and splenic macrophages using liposomes encapsulating the drug dichloromethylene diphosphonate: effects on antimicrobial resistance. J Leukoc Biol (1991) 0.92
The pineal control of aging. The effects of melatonin and pineal grafting on the survival of older mice. Ann N Y Acad Sci (1991) 0.92
Activated macrophages mediate interferon-independent inhibition of herpes simplex virus. Cell Immunol (1981) 0.92
Macrophage activation and anti-tumor activity of biologic and synthetic agents. Int J Cancer (1976) 0.91
Immunologic alterations in bleomycin-treated mice: role of pulmonary fibrosis in the modulation of immune responses. Am J Respir Crit Care Med (1996) 0.91
Effect of pyran on latency after herpes simplex virus infections. Antimicrob Agents Chemother (1979) 0.91
Comparison of various macrophage-inhibitory agents on vaginal and systemic herpes simplex virus type 2 infections. Infect Immun (1978) 0.91
Maintenance of peritoneal macrophages in the steady state. J Leukoc Biol (1988) 0.91
Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action. Proc Soc Exp Biol Med (1999) 0.90
Chromatin and histones in mealy bug cell explants: activation and decondensation of facultative heterochromatin by a synthetic polyanion. Chromosoma (1971) 0.90
Immunologic tolerance to HGG in mice. I. Suppression of the HGG response in normal mice with spleen cells or a spleen cell lysate from tolerant mice. J Immunol (1977) 0.90
Encephalitis associated with carcinoma. Central hypoventilation syndrome and cytoplasmic inclusion bodies. J Neurol Neurosurg Psychiatry (1974) 0.90
Molecular mechanism of RU 486 action: a review. Mol Cell Biochem (1992) 0.90
T-lymphocyte heterogeneity in the rat: separation of distinct rat T-lymphocyte populations which respond in syngeneic and allogeneic mixed lymphocyte reactions. Cell Immunol (1984) 0.90
Implementing a comprehensive approach to managing faculty roles, rewards, and development in an era of change. Acad Med (1997) 0.89
Pyran and polyribonucleotides: differences in biological activities. Antimicrob Agents Chemother (1972) 0.89
The requirement for surface Ig signaling as a prerequisite for T cell:B cell interactions. A possible role for desialylation. J Immunol (1988) 0.89
The oral-facial-digital syndromes reviewed: the role of computerized axial tomography in management. Ariz Med (1980) 0.89
Inhibition of cell-mediated immunity in patients with brain tumors. Surg Neurol (1976) 0.89
Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci (1986) 0.88
Idiopathic pneumonia syndrome after allogeneic bone marrow transplantation in mice. Role of pretransplant radiation conditioning. Am J Respir Cell Mol Biol (1999) 0.88
Malignant hyperthermia associated with myopathy and normal muscle enzymes. J Pediatr (1977) 0.88
Chloramphenicol-associated encephalopathy. Clin Pharmacol Ther (1970) 0.88
Tissue localization studies in evaluating the functional role of the RES. J Reticuloendothel Soc (1970) 0.88
Decreases in macrophage mediated antitumor activity with aging. Mech Ageing Dev (1995) 0.88
Age-related cellular resistance of the chicken embryo to viral infections. II. Inducible resistance produced by influenza virus and Escherichia coli. J Infect Dis (1970) 0.88
Cellular aspects of tolerance. II. Unresponsiveness of B cells. Cell Immunol (1973) 0.88
Macrophage mediated tumor cell cytotoxicity. Ann N Y Acad Sci (1976) 0.87